Objective: This prospective study was designed to assess the relationship between variations of serum Aluminium levels and bone mineralization, which is one of its target tissues, in healthy premature (PT) and fullterm (FT) infants. Study design: Lumbar spine bone mineral density (BMD) and content (BMC) studied by dual energy X-ray absorptiometry were compared to serum aluminium (S-Al), Ca (S-Ca), P (S-P), osteocalcin, alkaline phosphatase activity (S-AP), and 25 OH Vitamin D (25 OH D) by simple and multiple regressions in healthy PT (n 44) following their hospital discharge and FT (n 82). PT (gestational age at birth (mean AE 1 s.d.) 32 AE 2 weeks) and FT were 43AE 39 and 36 AE 32 weeks old respectively. Results: In PT multiple stepwise regression analysis including gestational age at birth, postconceptional age and postnatal age displayed only a signi®cant correlation between BMD or BMC and postnatal age and a negative one with S-Al. In FT correlations were found between BMD or BMC and age and S-Ca. Conclusions: In PT, variations in blood Al are associated with developmental delays. Care should be taken to lessen Al levels, even in healthy PT babies. Descriptors: bone mineral density; bone mineral content; aluminium; preterm infants; fullterm infants
Introduction
Aluminium (Al) has a well known toxicity for bone, liver, brain, and hematopoietic system (Alfrey, 1986) . Healthy adults are protected from Al accumulation by a low (`1%) digestive absorption of ingested intake and by the renal excretion of most of the absorbed fraction (Alfrey, 1986) ; therefore Al loading has been ®rst described in patients with Al parenteral supply andaor renal failure; tissue Al loading were described at necropsy of critically ill premature infants (PT), due to IV feeding and renal failure (Freundlich et al, 1985; Sedman et al, 1985; Bishop et al, 1989; Bozynski et al, 1989) . While in the young, growing rat, small variations of Al intakes above the usual diet concentrations were shown to impair bone mineralization (Boudey et al, 1997) , little is known, however, on the potential Al toxicity in the healthy infant: increased Al plasma levels were reported in full term infants fed Al rich formulas or antacids containing Al (Goyens & Brasseur, 1990; Tsou et al, 1991; Hawkins et al, 1994) and in healthy, renal disease free PT either IV (Stockhausen et al, 1990) or enterally fed (Bougle Â et al, 1992) ; some others observed nonsigni®cant trend toward correlations (Moreno et al, 1994) . Whether these variations in blood Al levels represent a risk for the development of healthy infants remains unknown (Bishop, 1992; Committee on Nutrition, 1996) ; serum Al, however, is higher in PT with than without fractures or rickets (Koo et al, 1992) .
The aim of this study was to compare bone mineralization to Al plasma levels and usual parameters of calcium metabolism in healthy infants formerly born prematurely or at term (FT).
Subjects and methods
PT were studied ataor following hospital discharge; they were all growing, formula fed babies; none took any drug known to contain Al such as antacids and none had renal failure. FT were healthy infants attending a routine visit at the outpatient clinic of the pediatric department. Parents gave their informed consent to the study which was approved by the Ethic Committee of the County of Basse-Normandie; a blood sample was obtained for the dosage of serum levels of Calcium (S-Ca), Phosphorus (S-P), alkaline phosphatase activity (S-AP), 25 OH Vitamin D (25 OHD), osteocalcin and Al (S-Al); S-Al was measured by Atomic Absorption Spectrometry on a Perkin Elmer 3030, such as previously described (Bougle Â et al, 1992) . The detection limit of the method is 0.13 mgadl (0.005 mmoladl); the precision on one day is 1.05 AE 0.017 mmolal, variation 1.62% (n 20); the precision on various days is 1.08 AE 0.043 mmolal, variation 4.0% (n 20).
The day of drawing blood, a bone densitometry of the lumber spine was performed by dual energy X-ray absorptiometry (DEXA) using an ODX 240 DEXA, (ORIS CEA, Saclay, France). Precision of measure is 1%.
The relationships between bone mineral density (BMD), bone mineral content (BMC) and clinical and biological data were assessed by simple and multiple stepwise regression analysis using StatView SE , Graphics TM 1988, (Abacus Concept Inc.) .
Results
Clinical data concerning the infants are given in Table 1 . In FT infants a multiple regression analysis was performed between clinical parameters (gestational age at birth, postnatal age, weight and height at study) and BMD or BMC: it was highly signi®cant (F 121, F 179 respectively; P 0.0001) for BMD and BMC; BMD was only correlated with height (partial F 27); BMC was correlated with postnatal age (partial F 16) and height (partial F 17). The correlation between postnatal age and biological parameters and mineralization was ®rst assessed by simple regression analysis: a signi®cant correlation was found with S-Ca (P `0.001), S-P (P `0.001), BMD (P`0.001) and BMC (P`0.001); no correlation was found with osteocalcin, S-AP, 25 OH D, nor with S-Al.
In PT a multiple regression analysis was performed between clinical parameters (gestational age at birth, postnatal age, posconceptional age, weight and height at study) and BMD or BMC: yet both tests gave signi®cant results (F 39, F 68 respectively; P 0.0001) none of these parameters was signi®cantly related to BMD or BMC. The regression analysis with gestational age at birth, posconceptional age and postnatal age as independent variables is given in Table 2 ; S-P and osteocalcin displayed a positive correlation, and S-Al a negative one with postnatal age; BMD and BMC were correlated with postnatal and gestational age at birth. S-AP was correlated with gestational age at birth; no correlations were found for S-Ca or 25 OH D.
Simple regressions between BMD and BMC and other parameters are given in Table 3 ; in FT signi®cant correlations were found between BMD or BMC and S-Ca, S-P, 25 OH D, S-AP and osteocalcin. PT displayed a negative correlation between BMD or BMC and S-P, S-Al, and osteocalcin.
Thereafter multiple stepwise regressions were performed between BMD or BMC as dependent variables and parameters with which a signi®cant relation was displayed by previous regression analysis. Postnatal age and gestational age at birth were added to biological independent variables as confounding variables in these multiple regressions. The results are given in the Table 4 , and in Figures 1 and 2 . In FT BMD and BMC were only correlated with postnatal age and S-Ca. In PT they were correlated with postnatal age and S-Al.
Discussion
High Al plasma levels were reported in hospitalized, sick, premature newborns (Freundlich et al, 1985; Sedman et al, 1985; Bishop et al, 1989; Bozynski et al, 1989) ; these values increase with age during the ®rst weeks of life (Bougle Â et al, 1992 ); yet in sick infants they were associated with Al tissue accumulation, it is not known so far if variations of Al levels are liable to have any signi®cance in absence of life threatening events in healthy infants, either Bone mineralization and aluminium in the healthy infant D Bougle Â et al PT or FT (Goyens & Brasseur, 1990; Bishop, 1992; Committee on Nutrition, 1996) . Almost all premature infants showed some degree of hypomineralization or frank osteopenia during their evolution (Beyers et al, 1994; Greer, 1994) . The etiology of this metabolic bone disease is multifactorial: the main suggested factors are low Ca and low P supply and bioavailability, and Vitamin D de®ciency (Beyers et al, 1994; Greer, 1994) . Since bone is one of the target tissue of Al toxicity (Alfrey, 1986) , this study looked at the relationship which could occur between this osteopenia and variations of blood Al. The rather high serum Al levels displayed by some infants, both preterm and fullterm, could not be explained by drug intake or renal failure at the time of the study. These instant values, however, were only related with bone mineralization in preterms. BMD and BMC were similar to previously reported normal values (Pettifor et al, 1989; Salle et al, 1992; Schanler et al, 1992; Tsukahara et al, 1993) .
As expected, this study showed that postnatal age is the main determining factor of bone mineralization in PT and FT infants (Hillman et al, 1988; Glastre et al, 1990; Pittard et al, 1990; Rubinacci et al, 1993) . The in¯uence of gestational age at birth on bone mineralization of PT (Salle et al, 1992) , which was suggested by simple regression, did not remain signi®cant when regression included postnatal age (Bishop et al, 1993) .
Similarly, simple regression displayed signi®cant correlations between bone mineralization and several biological parameters namely, S-P, S-Al and osteocalcin in PT, and S-Ca, S-P, S-AP, 25 OH D and osteocalcin in FT; multiple regression, however, showed that among the different biological parameters which were tested, bone mineralization was only associated with S-Al, in the PT, and with S-Ca and S-P in FT infant, during several months after birth.
It is not known whether an increase in blood Al is liable to impair bone mineralization or if it is an indicator of organ storage: the increase of Al serum levels which occurs in PT during the ®rst weeks of life (Bougle Â et al, 1992) and the decrease which was observed in the present study after their discharge from hospital suggest that Al could accumulate early and be slowly released from loaded tissues during growth turnover. PT are at higher risk of Al loading Bone mineralization and aluminium in the healthy infant D Bougle Â et al than FT infants, according to higher Al supply, and renal immaturity: due to neonatal illness they are often IV fed with Al rich solutes (Koo et al, 1986; Chappuis et al, 1991) ; later they are fed low-birth-weight formulas which are more Al contaminated than standard formulas (Koo et al, 1988; Bougle Â et al, 1989) . Renal immaturity of PT could impair Al excretion which is delayed even by a moderate decrease of renal functions (Mertz, 1986) , and explain the slow decrease of Alacreatinine ratio in urine (Moreno et al, 1994) . Therefore in PT the risk of tissue loading is increased by high intakes andaor absorption and low excretion rate.
Interactions between Al and Ca occur at every step of their metabolism: they share the same saturable Vitamin D dependent absorption pathway (Adler et al, 1991; Moon et al, 1992; Dunn et al, 1993) ; Al and P interact in the digestive tract to form insoluble complexes (Moon et al, 1992) .
Al effects on bone are both direct by inhibiting its mineralization, and indirect through interactions with Ca and P metabolism: Al is deposited at the calci®cation front, preventing further mineralization of osteoids (Boudey et al, 1997) ; it may reduce the total quantity of mineralizable osteoids and induces Ca release from bone (Bushinsky et al, 1995) .
Several studies compared bone mineralization to its related biological parameters in PT (Greer et al, 1991 (Greer et al, , 1994 Pittard et al, 1990; Lucas et al, 1992; Namgung et al, 1993 Namgung et al, , 1994 Chan, 1993; Ryan et al, 1993; Hayashi et al, 1994; Pohlandt, 1994) , and in FT (Roberts et al, 1981; Schanler et al, 1992; Namgung et al, 1994) ; only part of PT show signi®cant correlations between BMD or BMC and S-Ca (Pettifor et al, 1989; Tsukahara et al, 1993) or 25 OH D (Chan, 1993) . P de®ciency is a limiting factor of bone mineralization (Brooke & Lucas, 1985; Greer et al, 1991 Greer et al, , 1994 , as shown by its statistical correlation with BMD and BMC (Pettifor et al, 1989; Chan, 1993; Ryan et al, 1993) , and by the positive effect of its dietary supplementation on bone mineralization (Hayashi et al, 1994; Pohlandt, 1994) . The relationships displayed between bone mineralization and S-AP (Abrams et al, 1988; Chan, 1993; Ryan et al, 1993) is in agreement with the high turnover osteopenia (Greer, 1994) . However even when such correlations were found, they could only explain part of the variation of bone mineralization in the PT (Abrams, 1988; Ryan et al, 1993) .
In FT infants, BMC is not correlated with S-Ca, S-P, osteocalcin or 25 OH D (Roberts et al, 1981; . Therefore in healthy FT development of bone mineralization seems to be partly independent of nutritional variations; on the contrary even healthy PT seem to be able to accumulate Al, that could have long term detrimental effects, on bone such as on neurologic development (Bishop et al, 1997) .
Conclusions
In preterm infants Al serum levels and age appear to be mainly associated with the development of bone Figure 1 Relationship between serum Al levels (mmolal) and BMD (gacm 2 ) and BMC (g) in healthy premature infants, assessed by multiple stepwise regression. Preterm infants. Figure 2 Relationship between serum Al levels (mmolal) and BMD (gacm 2 ) and BMC (g) in healthy fullterm infants, assessed by multiple stepwise regression.
Bone mineralization and aluminium in the healthy infant D Bougle Â et al mineralization, as compared to the usual parameters of Ca metabolism; although the causal relationship between increased Al levels and impaired bone mineralization is not precisely determined, this observation points at the great dependence of preterm infants on environmental and nutritional factors, which are liable to have long term developmental effects; on the other hand, the development of bone mineralization seems to be more ef®ciently regulated in fullterm infants. Exposure of PT to Al should be reduced.
